Group | N | Methylation (mean ± SD) |
---|
Control | 52 | 6.9% ± 2.5% |
Leukemia | 32 | 28.9% ± 17.8% ** |
- ** p = <0.001 in comparison to controls
- In the control group, one individual exhibited a PLA2R1 methylation of 21% and in the leukemic group, two patients had methylations of 7% and 3% (patient details see in Additional file 1: TableS1). The 95th percentile value usable as cut-off averaged 9%.